VitaTech International Inc. announced reaffirmation of its FDA pharmaceutical licensing and new investment of over $2 million in enhanced production capabilities for the manufacturing of tablets, powders and two-piece capsules. A private label manufacturer of vitamins and nutritional supplements for new and established brands worldwide in health and nutrition, VitaTech has been pharmaceutically licensed since 1954.
"Orders are up and we are off to a great start in 2012," commented CEO Thomas T. Tierney. "Our expertise in product innovation and our commitment to staying ahead of customer wants and regulatory needs has produced excellent results," he said. Tierney attributes the company's growth to its strategic partnerships and its culture of dedication to the success of its customers. "We are a trusted partner, making every detail work in a heavily regulated and highly competitive industry," he said.
VitaTech's recent investment in state-of-the-art tablet and capsule fillers enables the company to press an additional 250,000 tablets per hour, bringing capacity to 3.8 billion tablets per year. "We place a premium on rapid turnaround," says Tierney.
With the installation of segregated overhead feed systems and new technology to automatically reject non-conforming tablets and capsules, VitaTech added enhanced speed and quality assurance to its manufacturing.
The company has expanded encapsulation production, with capacity of up to 1.2 billion capsules annually. Recent investments in quality control and EDI solutions provide speed, improved data accuracy and streamlined interactions with trading partners.
Leading the West Coast in capacity for continuous coating of vitamins and nutraceuticals, VitaTech also provides comprehensive analytical testing services. Heavy metals and microbiological testing are available on-site in the company's quality assurance/quality control analytical laboratory.
VitaTech has been pharmaceutically licensed since 1954.